Medtronic plc (MDT)
USD 80.03
(-1.65%)
USD 80.03
(-1.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 9.05 Billion USD | -3.21% |
| 2023 | 8.47 Billion USD | 1.23% |
| 2022 | 9.55 Billion USD | 12.59% |
| 2021 | 8.19 Billion USD | -3.74% |
| 2020 | 7.82 Billion USD | -14.72% |
| 2019 | 9.36 Billion USD | 2.98% |
| 2018 | 9.18 Billion USD | -2.21% |
| 2017 | 9.02 Billion USD | 4.18% |
| 2016 | 8.53 Billion USD | 47.4% |
| 2015 | 6.27 Billion USD | -6.35% |
| 2014 | 5.64 Billion USD | 12.02% |
| 2013 | 5.53 Billion USD | 13.29% |
| 2012 | 5.32 Billion USD | -22.25% |
| 2011 | 5.05 Billion USD | 34.27% |
| 2010 | 5.14 Billion USD | -0.55% |
| 2009 | 3.51 Billion USD | -16.07% |
| 2008 | 3.63 Billion USD | 28.4% |
| 2007 | 4.32 Billion USD | -3.66% |
| 2006 | 4.17 Billion USD | 0.56% |
| 2005 | 3.06 Billion USD | 20.95% |
| 2004 | 3.62 Billion USD | 19.14% |
| 2003 | 3.06 Billion USD | 8.71% |
| 2002 | 2.47 Billion USD | 20.09% |
| 2001 | 2.17 Billion USD | 36.85% |
| 2000 | 1.92 Billion USD | -6.07% |
| 1999 | 1.57 Billion USD | 69.07% |
| 1998 | 1.25 Billion USD | 36.81% |
| 1997 | 1.04 Billion USD | 18.87% |
| 1996 | 748 Million USD | 38.2% |
| 1995 | 542.8 Million USD | 35.77% |
| 1994 | 411.2 Million USD | 15.78% |
| 1993 | 364.7 Million USD | 13.83% |
| 1992 | 305.4 Million USD | 18.37% |
| 1991 | 252.9 Million USD | 23.73% |
| 1990 | 204.4 Million USD | 17.27% |
| 1989 | 174.3 Million USD | 9.55% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 2.18 Billion USD | 13.55% |
| 2024 Q1 | 2.11 Billion USD | -15.38% |
| 2024 Q2 | 2.27 Billion USD | 5.69% |
| 2024 Q3 | 1.48 Billion USD | -0.45% |
| 2024 FY | - USD | -7.33% |
| 2023 Q1 | 1.73 Billion USD | -27.51% |
| 2023 Q3 | 2.25 Billion USD | 3.43% |
| 2023 Q4 | 2.68 Billion USD | 18.68% |
| 2023 Q2 | 2.18 Billion USD | 25.59% |
| 2023 FY | - USD | 1.23% |
| 2022 FY | - USD | 12.59% |
| 2022 Q3 | 2.44 Billion USD | 4.09% |
| 2022 Q2 | 2.34 Billion USD | 39.99% |
| 2022 Q1 | 1.67 Billion USD | -31.57% |
| 2022 Q4 | 2.39 Billion USD | -1.88% |
| 2021 FY | - USD | -3.74% |
| 2021 Q2 | 1.84 Billion USD | 32.97% |
| 2021 Q3 | 2.24 Billion USD | 21.6% |
| 2021 Q4 | 2.45 Billion USD | 9.17% |
| 2021 Q1 | 1.38 Billion USD | 25.36% |
| 2020 Q2 | 2.27 Billion USD | -2.52% |
| 2020 Q3 | 2.51 Billion USD | 10.58% |
| 2020 Q1 | 2.33 Billion USD | -15.42% |
| 2020 FY | - USD | -14.72% |
| 2020 Q4 | 1.1 Billion USD | -56.01% |
| 2019 Q1 | 2.25 Billion USD | -17.77% |
| 2019 Q2 | 2.24 Billion USD | -0.44% |
| 2019 Q3 | 2.39 Billion USD | 6.78% |
| 2019 Q4 | 2.76 Billion USD | 15.37% |
| 2019 FY | - USD | 2.98% |
| 2018 Q3 | 2.28 Billion USD | 6.53% |
| 2018 FY | - USD | -2.21% |
| 2018 Q1 | 2.21 Billion USD | -18.41% |
| 2018 Q2 | 2.14 Billion USD | -3.25% |
| 2018 Q4 | 2.74 Billion USD | 19.96% |
| 2017 Q2 | 2.28 Billion USD | 2.61% |
| 2017 FY | - USD | 4.18% |
| 2017 Q4 | 2.71 Billion USD | 14.5% |
| 2017 Q1 | 2.22 Billion USD | -15.24% |
| 2017 Q3 | 2.37 Billion USD | 3.9% |
| 2016 Q3 | 2.25 Billion USD | 0.0% |
| 2016 Q4 | 2.62 Billion USD | 16.61% |
| 2016 FY | - USD | 47.4% |
| 2016 Q1 | 2.08 Billion USD | 32.72% |
| 2016 Q2 | 2.25 Billion USD | 7.96% |
| 2015 Q4 | 1.57 Billion USD | 3.49% |
| 2015 FY | - USD | -6.35% |
| 2015 Q2 | 1.56 Billion USD | 7.96% |
| 2015 Q1 | 1.44 Billion USD | -39.13% |
| 2015 Q3 | 1.51 Billion USD | -2.69% |
| 2014 FY | - USD | 12.02% |
| 2014 Q1 | 1.32 Billion USD | -24.07% |
| 2014 Q3 | 1.56 Billion USD | 10.92% |
| 2014 Q2 | 1.41 Billion USD | 6.42% |
| 2014 Q4 | 2.37 Billion USD | 51.79% |
| 2013 Q3 | 1.3 Billion USD | -1.29% |
| 2013 Q2 | 1.32 Billion USD | -0.08% |
| 2013 Q1 | 1.32 Billion USD | -11.15% |
| 2013 FY | - USD | 13.29% |
| 2013 Q4 | 1.74 Billion USD | 33.72% |
| 2012 FY | - USD | -22.25% |
| 2012 Q4 | 1.48 Billion USD | 13.58% |
| 2012 Q3 | 1.31 Billion USD | 2.18% |
| 2012 Q2 | 1.28 Billion USD | 0.39% |
| 2012 Q1 | 1.27 Billion USD | -27.76% |
| 2011 Q4 | 1.76 Billion USD | 35.87% |
| 2011 FY | - USD | 34.27% |
| 2011 Q2 | 1.03 Billion USD | -20.52% |
| 2011 Q1 | 1.3 Billion USD | -16.55% |
| 2011 Q3 | 1.3 Billion USD | 25.92% |
| 2010 Q4 | 1.55 Billion USD | 6.71% |
| 2010 FY | - USD | -0.55% |
| 2010 Q1 | 1.32 Billion USD | 240.46% |
| 2010 Q2 | 1.34 Billion USD | 2.04% |
| 2010 Q3 | 1.46 Billion USD | 8.38% |
| 2009 Q2 | 1.7 Billion USD | 4.6% |
| 2009 Q1 | 1.62 Billion USD | -4.9% |
| 2009 Q4 | 388 Million USD | -71.13% |
| 2009 Q3 | 1.34 Billion USD | -21.13% |
| 2009 FY | - USD | -16.07% |
| 2008 Q2 | 1.07 Billion USD | -9.56% |
| 2008 Q4 | 1.71 Billion USD | -16.56% |
| 2008 FY | - USD | 28.4% |
| 2008 Q1 | 1.19 Billion USD | -15.94% |
| 2008 Q3 | 2.05 Billion USD | 90.45% |
| 2007 Q3 | 1.12 Billion USD | 1.17% |
| 2007 FY | - USD | -3.66% |
| 2007 Q1 | 1.12 Billion USD | -8.49% |
| 2007 Q2 | 1.11 Billion USD | -1.51% |
| 2007 Q4 | 1.41 Billion USD | 26.16% |
| 2006 Q3 | 1.03 Billion USD | -11.49% |
| 2006 Q4 | 1.23 Billion USD | 18.67% |
| 2006 Q2 | 1.17 Billion USD | -18.12% |
| 2006 Q1 | 1.43 Billion USD | -20.33% |
| 2006 FY | - USD | 0.56% |
| 2005 Q1 | 961.1 Million USD | -20.0% |
| 2005 Q2 | 986.8 Million USD | 2.67% |
| 2005 Q3 | 1.1 Billion USD | 11.92% |
| 2005 FY | - USD | 20.95% |
| 2005 Q4 | 1.79 Billion USD | 62.91% |
| 2004 Q3 | 999.6 Million USD | 25.91% |
| 2004 Q2 | 793.9 Million USD | -8.93% |
| 2004 FY | - USD | 19.14% |
| 2004 Q1 | 871.7 Million USD | -7.25% |
| 2004 Q4 | 1.2 Billion USD | 20.18% |
| 2003 Q1 | 682.1 Million USD | -22.25% |
| 2003 Q4 | 871 Million USD | 15.13% |
| 2003 Q3 | 767.8 Million USD | -8.52% |
| 2003 Q2 | 740.8 Million USD | 24.21% |
| 2003 FY | - USD | 8.71% |
| 2002 Q3 | 612.5 Million USD | -23.14% |
| 2002 FY | - USD | 20.09% |
| 2002 Q4 | 731.4 Million USD | 36.06% |
| 2002 Q2 | 587.4 Million USD | 44.78% |
| 2002 Q1 | 547.5 Million USD | -33.53% |
| 2001 Q3 | 540.5 Million USD | 11.3% |
| 2001 Q2 | 513.5 Million USD | -0.29% |
| 2001 Q1 | 527 Million USD | -4.02% |
| 2001 FY | - USD | 36.85% |
| 2001 Q4 | 594.9 Million USD | 58.27% |
| 2000 Q3 | 445.8 Million USD | -5.01% |
| 2000 Q4 | 545.5 Million USD | 22.16% |
| 2000 FY | - USD | -6.07% |
| 2000 Q1 | 415.1 Million USD | -17.34% |
| 2000 Q2 | 475.5 Million USD | 13.06% |
| 1999 FY | - USD | 69.07% |
| 1999 Q1 | 395.1 Million USD | -10.11% |
| 1999 Q2 | 371.7 Million USD | 14.53% |
| 1999 Q3 | 380.2 Million USD | 126.03% |
| 1999 Q4 | 399.9 Million USD | -22.37% |
| 1998 FY | - USD | 36.81% |
| 1998 Q4 | 283.7 Million USD | -33.59% |
| 1998 Q1 | 254.5 Million USD | 8.48% |
| 1998 Q2 | 249.9 Million USD | -3.53% |
| 1998 Q3 | 288.3 Million USD | 73.98% |
| 1997 Q4 | 236.9 Million USD | 11.22% |
| 1997 Q3 | 216.4 Million USD | -2.82% |
| 1997 Q2 | 221.4 Million USD | -2.43% |
| 1997 Q1 | 226.7 Million USD | 11.22% |
| 1997 FY | - USD | 18.87% |
| 1996 Q2 | 183.9 Million USD | -0.62% |
| 1996 Q4 | 204.9 Million USD | 7.99% |
| 1996 Q3 | 187.9 Million USD | 2.89% |
| 1996 Q1 | 183.9 Million USD | 17.16% |
| 1996 FY | - USD | 38.2% |
| 1995 Q1 | 128.5 Million USD | 7.96% |
| 1995 Q2 | 126.8 Million USD | -1.74% |
| 1995 Q4 | 157.4 Million USD | 20.05% |
| 1995 Q3 | 130 Million USD | 1.77% |
| 1995 FY | - USD | 35.77% |
| 1994 Q2 | 106.3 Million USD | 54.91% |
| 1994 Q1 | 82.8 Million USD | -34.38% |
| 1994 Q3 | 103.3 Million USD | -3.17% |
| 1994 Q4 | 118.9 Million USD | 15.97% |
| 1994 FY | - USD | 15.78% |
| 1993 Q4 | 104.9 Million USD | 21.04% |
| 1993 Q3 | 86.9 Million USD | 31.78% |
| 1993 Q1 | 87.8 Million USD | -11.59% |
| 1993 Q2 | 85.8 Million USD | -24.82% |
| 1993 FY | - USD | 13.83% |
| 1992 Q3 | 69.5 Million USD | -2.48% |
| 1992 Q2 | 71.3 Million USD | 9.06% |
| 1992 Q1 | 65.1 Million USD | -12.76% |
| 1992 Q4 | 99.5 Million USD | 44.39% |
| 1992 FY | - USD | 18.37% |
| 1991 Q4 | 74.5 Million USD | 22.83% |
| 1991 Q1 | 54.1 Million USD | -1.32% |
| 1991 Q2 | 57.1 Million USD | 4.79% |
| 1991 Q3 | 58.7 Million USD | 7.31% |
| 1991 FY | - USD | 25.03% |
| 1990 Q4 | 54.5 Million USD | 4.96% |
| 1990 FY | - USD | 37.23% |
| 1990 Q3 | 51.9 Million USD | 3.28% |
| 1990 Q2 | 49.6 Million USD | -74.57% |
| 1990 Q1 | 191.9 Million USD | 146.34% |
| 1989 Q3 | 186.8 Million USD | 3.09% |
| 1989 Q1 | 175.8 Million USD | 152.63% |
| 1989 FY | - USD | -4.66% |
| 1989 Q2 | 181.2 Million USD | 3.07% |
| 1989 Q4 | -414.1 Million USD | -321.68% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 13.447% |
| Allurion Technologies Inc. | -69.03 Million USD | 13218.744% |
| Artivion, Inc. | 38.14 Million USD | -23642.856% |
| Avanos Medical, Inc. | 53.2 Million USD | -16922.556% |
| Butterfly Network, Inc. | -124.84 Million USD | 7353.853% |
| Butterfly Network, Inc. | -124.84 Million USD | 7353.853% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 1588.825% |
| Boston Scientific Corporation | 3.45 Billion USD | -162.265% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | 61132.484% |
| CONMED Corporation | 182.18 Million USD | -4870.744% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | -412.333% |
| Paragon 28, Inc. | -36.61 Million USD | 24833.708% |
| Glaukos Corporation | -82.11 Million USD | 11128.301% |
| Globus Medical, Inc. | 418.23 Million USD | -2065.269% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | 53183.236% |
| Integer Holdings Corporation | 282.05 Million USD | -3110.676% |
| Nevro Corp. | -78.31 Million USD | 11664.296% |
| Owlet, Inc. | -27.48 Million USD | 33044.087% |
| Penumbra, Inc. | 111.99 Million USD | -7986.003% |
| Vicarious Surgical Inc. | -69.19 Million USD | 13188.218% |
| Smith & Nephew plc | 979 Million USD | -825.026% |
| Sonendo, Inc. | -54.76 Million USD | 16635.203% |
| STERIS plc | 1.41 Billion USD | -541.176% |
| Stryker Corporation | 5.16 Billion USD | -75.504% |
| Vapotherm, Inc. | -34.35 Million USD | 26458.53% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | -269.799% |